1Lukehart SA, Hook EW, Baker - Zander SA, et al. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment. Ann Inter Med, 1988, 109(11): 855- 862.
2Marra CM, Lastro CD, KullerL, et al. Mechanism of clearance of Treponema pellidum from the CSF in a nonhuman primate model. Neurology, 1998, 51(4):957-961.
3Smith W. Cecil textbook of medicine. 17ed, Japan: Seunders Company, 1985, 2118-2119.
5Sellati TJ, Wilkinspn DA, Sheffield JS, et al. Virulent treponema pallidum, lipoprotein, and synthetic lipopetides induce CCR5 on human monocytes and enhance their susceptibility to infection by human immunodeficiency virus typel. J Infect Dis 2000, 181(1):283-293
6Greene SR, Stamm LV. Molecular characterization of Treponema pallidum mcp2, a putative chemotaxis protein gene. Infect Immunm,1998, 66(6) :2999- 3002.
7Kawai W, Baba A, Mizukami K, et al. CT, MR, SPECT findings in a generalparesis. Computer Med Imaging Graph, 1994, 18(6):461 -465.
8Stamm NE, Handsfield HH, Rompalo AM, et al. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA, 1988, 260(10):1429- 1433.
9Katz DA, Berger JR. Neurosyphilis in acquired immunodeficiency Syndrome. Arch Neurol, 1989, 46(8): 895 - 898.
10Johns DR, Tierney M, Felsenstein D. Alteration in the natural history of neurosyphilis by concurrent infection with the human immunodeficiency virus. N Engl J Med, 1987, 316(25): 1569 - 1572.